Arterial and Venous Occlusive Disease of the Retina - PowerPoint PPT Presentation

1 / 38
About This Presentation
Title:

Arterial and Venous Occlusive Disease of the Retina

Description:

SLides 1 to 8 Stops at ACh activatin of Kca 1st time ... Dr.M NAQEEB Assistant professor Um Al-Qura university Objective Central retinal artery occlusion Branch ... – PowerPoint PPT presentation

Number of Views:640
Avg rating:3.0/5.0
Slides: 39
Provided by: Corporate76
Category:

less

Transcript and Presenter's Notes

Title: Arterial and Venous Occlusive Disease of the Retina


1
Arterial and Venous Occlusive Disease of the
Retina
Dr.M NAQEEB Assistant
professor Um Al-Qura university
2
Objective
  • Central retinal artery occlusion
  • Branch retinal artery occlusion
  • Branch retinal vein occlusion
  • Central retinal vein occlusion

3
retinal artery obstructions
  • 57 of obstructions involved the central retinal
    artery
  • 38 involved one of the branch retinal arteries
  • 5 involved the cilioretinal artery

4
Central Artery Obstruction
  • Characteristics
  • Sudden severe visual loss
  • Painless
  • Retinal appearance
  • Opaque and edematous
  • Most prominent in posterior pole
  • Thickest ganglion cell layer
  • Cherry-red spot
  • Visible intact choroidal vasculature beneath the
    foveola

5
Central Artery Obstruction
  • Characteristics
  • With time
  • Artery re-canalizes
  • Edema clears
  • Visual loss is devastating and permanent
  • Irreversible damage to neural tissue after 90
    minutes

6
Intravenous fluorescein angiography
7
Central Artery Obstruction
  • Prognosis
  • 20/400 or worse 2/3 of eyes
  • 20/40 or better 1/6 eyes
  • Intact cilioretinal artery
  • Vision of NLP
  • Implies ophthalmic artery occlusion
  • Choroidal ischemia as well

8
Central Artery Obstruction
  • Pathogenesis
  • Majority
  • atherosclerosis-related thrombosis
  • At the level of the lamina cribrosa
  • Other causes
  • Arterial spasm
  • Dissecting aneurysm
  • GIANT CELL ARTERITIS
  • 1 of cases
  • Check ESR in elderly patients!
  • Start high does steroids if suspicious

9
Central Artery Obstruction
  • Management
  • No good therapy exists, all treatments
    questionable
  • Ocular message
  • Anterior chamber paracentesis
  • Attempt to acutely reduce IOP
  • Dislodge thrombosis
  • Inhalation therapy
  • 95O2, 5CO2
  • Stimulate vasodilatation
  • Iris neovascularization
  • Occurs in 18 of eyes
  • 1-12 weeks later (usually 3-4 weeks later)
  • Full PRP treatment required

10
Branch Retinal Artery Obstruction
  • Characteristics
  • Vision loss
  • Visual filed defect
  • Within hours/days
  • Edematous opacification of the retina
  • In the distribution of the affected vessel

11
Branch Retinal Artery Obstruction
  • Pathogenesis
  • Embolization or thrombosis of vessel
  • Three types of emboli
  • Cholesterol
  • Hollenhorst plaques
  • Arise from carotid
  • Platelet-fibrin
  • Associated with arteriosclerosis
  • Calcific
  • Diseased cardiac valves

12
Retinal Embolization
  • Hollenhorst plaque
  • Glistening cholesterol emboli
  • Found within retinal arteriole
  • Typically lodge at bifurcations
  • Arise in carotid arteries

13
Retinal Embolization
  • Hollenhorst plaque
  • Glistening cholesterol emboli
  • Found within retinal arteriole
  • Typically lodge at bifurcations
  • Arise in carotid arteries

14
Branch Retinal Artery Obstruction
  • Other causes of BRVO
  • Migraine
  • Particularly in smokers
  • Trauma
  • Coagulation disorders
  • Sickle cell disease
  • Oral contraceptive use
  • Smoking, older women
  • Mitral valve prolapse
  • Infections
  • Toxoplasmosis, syphilis
  • Giant cell arteritis
  • Check ESR in elderly patients
  • Good prognosis

15
Workup
  • ESR,CBC and C-reactive protein
  • Fasting blood sugar
  • Glycosylated hemoglobin
  • Doppler US for carotid artery
  • ECG, echocardiogram
  • Refer for haematology

16
Mortality/Morbidity
  • Further emboli to the brain resulting in CVA
  • 55 death over 10 years
  • 27 age matched population
  • Further emboli to same or contralateral eye
    resulting in further visual loss
  • Progression of temporal arteritis

17
Venous Occlusive Disease
18
Central Retinal Vein Occlusion
  • Findings
  • Dilated and tortuous retinal veins
  • Swollen optic disc
  • Intra-retinal hemorrhages
  • Retinal edema

19
Central Retinal Vein Occlusion
  • Classification
  • Based on amount of non-profusion on fluorescein
    angiography
  • Ischemic
  • 10 disk areas
  • Non-ischemic
  • lt 10 disk areas
  • Indeterminate
  • Too much hemorrhage to tell
  • 80 progress to ischemic

20
Central Retinal Vein Occlusion
  • Pathogenesis
  • Thrombosis of the central retinal vein
  • At or posterior to the lamina cribrosa
  • Atherosclerotic central retinal artery
  • Impinges on central retinal vein
  • Turbulent flow ? thrombus

21
Central Retinal Vein Occlusion
  • Non-ischemic CRVO
  • Less dilation and vascular tortuosity
  • Dot and flame hemorrhages in all quadrants
  • Less or no disk swelling
  • Angiogram shows
  • Delayed A-V transit time
  • Leakage
  • Minimal capillary dropout
  • Neovascularization is rare

22
Central Retinal Vein Occlusion
  • Ischemic CRVO
  • Extensive hemorrhage
  • Retinal edema
  • Marked venous dilation
  • Cotton-wool spots
  • Angiogram show
  • Widespread capillary nonprofusion
  • Visual prognosis poor
  • Only 10 have gt20/400 vision
  • NVI
  • As high as 60 of eyes
  • Occurs 3-5 months post occlusion
  • the three month glaucoma

23
Central Retinal Vein Occlusion
  • Risk Factors
  • Eye Disease Case-Control Study
  • Hypertension
  • Diabetes
  • Unlike BRVO
  • Glaucoma
  • Check and treat IOP!
  • CRVO in young patients requires more extensive
    workup for cause

24
CRVO In Young Patients Causes
  • Systemic vascular disease
  • Hypertension
  • Diabetes mellitus
  • Cardiovascular disease
  • Blood dyscrasias
  • Polycythemia vera
  • Lymphoma
  • Leukemia
  • Clotting disorders
  • Activated protein C resistance
  • Lupus anticoagulant
  • Anticardiolipin antibodies
  • Protein C
  • Protein S
  • Antithrombin III
  • Paraproteinemia and dysproteinemias
  • Multiple myeloma
  • Cryoglobulinemia
  • Vasculitis
  • Syphilis
  • Sarcoidosis
  • Autoimmune disease
  • Systemic lupus erythematosus
  • Oral contraceptive use in women
  • Other rare associations
  • Closed-head trauma
  • Optic disc drusen
  • Arteriovenous malformations of retina

25
Central Retinal Vein Occlusion
  • Management
  • Family medical doctor to manage
  • Hypertension
  • Diabetes
  • Elevated cholesterol

26
Central Retinal Vein Occlusion
  • Management
  • Macular edema
  • Central Vein Occlusion Study Group
  • Grid laser treatment in the macula
  • DOES reduce angiographic evidence of edema
  • DOES NOT improve vision

27
Central Retinal Vein Occlusion
  • Management
  • Macular edema
  • Intravitreal trimcinolone/Avastin
  • Capable of transiently improving vision
  • Risks
  • Glaucoma
  • RD
  • Cataract
  • Endopthalmitis

28
Central Retinal Vein Occlusion
  • Management
  • Iris neovascularization
  • PRP to eyes prior to NVI
  • NO benefit
  • Even if very ischemic
  • Once neovascularization detected
  • Prompt PRP

29
Central Retinal Vein Occlusion
  • Outcome
  • Most important predictor is initial visual
    acuity
  • 20/40 or better
  • Likely to remain unchanged
  • 20/400 or less
  • Likely to remain worse than 20/400
  • 20/50-20/200
  • 1/3 unchanged
  • 1/3 improve
  • 1/3 worse

30
Branch Retinal Vein Occlusion
  • Findings
  • Within one sector of the retina
  • Superficial hemorrhages
  • Retinal edema
  • Cotton-wool spots
  • Dilated and tortuous vein
  • Corresponding artery narrowed and sheathed

31
Branch Retinal Vein Occlusion
  • Findings
  • Superotemporal quadrant most common
  • 63
  • Occurs at arteriovenous crossing
  • Artery and vein bound together in a common sheath
  • Arterial thickening compresses vein
  • Turbulent flow ? thrombus formation

32
Branch Retinal Vein Occlusion
  • Risk factors
  • Identified by the Eye Disease Case-Control Study
  • Hypertension
  • Cardiovascular disease
  • Increased BMI at age 20
  • Glaucoma
  • Note Diabetes not an independent risk factor

33
Branch Retinal Vein Occlusion
  • Visual Loss
  • Acute
  • Macular hemorrhage
  • Macular edema
  • Capillary occlusion
  • Chronic
  • Macular ischemia
  • CME
  • Macular pigmentary changes
  • Epiretinal membrane formation
  • Subretinal fibrosis

34
Branch Retinal Vein Occlusion
  • Photocoagulation
  • Used to treat
  • Macular edema
  • Requires intact foveal perfusion
  • Neovascularization
  • Macular edema
  • Allow three months for improvement
  • Vision 20/40 or worse
  • Light grid pattern of laser spots to involved
    sector of retina
  • Branch vein occlusion study
  • Treated eyes more likely to gain 2 lines of
    vision
  • Treated 65, untreated 37

35
(No Transcript)
36
Branch Retinal Vein Occlusion
  • Photocoagulation
  • Neovascularization
  • BVOS defined ischemic BRVO
  • Area of non-profusion gt 5 disk diameters
  • Large areas of non-profusion increase risk of
    neovascularization
  • Apply scatter PRP to areas of retinal ischemia
  • Only when neovascular complications develop
  • NVI, NVE, NVD

37
Branch Retinal Vein Occlusion
  • Photocoagulation
  • Must differentiate
  • Neovascular tissue
  • Leaks on fluorscein angiogram
  • Collateral vessels
  • Help to reduce vascular tissue
  • Do not treat

Vascular Remodeling
38
Thank you xoxo
Write a Comment
User Comments (0)
About PowerShow.com